172 related articles for article (PubMed ID: 21858550)
1. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.
Zhang X; Wu L; Sheng Y; Zhou W; Huang Z; Qu J; Gao G; Cai D; Zhang M
Mol Biol Rep; 2012 Mar; 39(3):2567-74. PubMed ID: 21858550
[TBL] [Abstract][Full Text] [Related]
2. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
[TBL] [Abstract][Full Text] [Related]
3. TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.
Skoglund Lundin J; Vandrovcova J; Song B; Zhou X; Zelada-Hedman M; Werelius B; Houlston RS; Lindblom A
Br J Cancer; 2009 May; 100(10):1674-9. PubMed ID: 19401691
[TBL] [Abstract][Full Text] [Related]
4. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
[TBL] [Abstract][Full Text] [Related]
5. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.
Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF
Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361
[TBL] [Abstract][Full Text] [Related]
6. TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer.
Martinez-Canto A; Castillejo A; Mata-Balaguer T; Castillejo MI; Hernandez-Illan E; Irles E; Barbera VM; Egoavil C; Guarinos C; Alenda C; Ochoa E; Lazaro R; Fajardo S; Lacueva J; Calpena R; Soto JL
PLoS One; 2012; 7(1):e30812. PubMed ID: 22292045
[TBL] [Abstract][Full Text] [Related]
7. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
[TBL] [Abstract][Full Text] [Related]
8. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
[TBL] [Abstract][Full Text] [Related]
9. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.
Wang YQ; Qi XW; Wang F; Jiang J; Guo QN
PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183
[TBL] [Abstract][Full Text] [Related]
10. TGFBR1*6A polymorphism in sporadic and familial colorectal Carcinoma: a case-control study and systematic literature review.
Ibrahim T; Yazbeck C; Maalouly G; Baz M; Haddad F; Sabbagh C; Chahine G
J Gastrointest Cancer; 2014 Dec; 45(4):441-7. PubMed ID: 24880985
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
[TBL] [Abstract][Full Text] [Related]
12. The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study.
Castillejo A; Mata-Balaguer T; Guarinos C; Castillejo MI; Martínez-Cantó A; Barberá VM; Montenegro P; Ochoa E; Lázaro R; Guillén-Ponce C; Carrato A; Soto JL
BMC Cancer; 2009 Nov; 9():406. PubMed ID: 19930569
[TBL] [Abstract][Full Text] [Related]
13. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study.
Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
BMC Cancer; 2010 Apr; 10():169. PubMed ID: 20429896
[TBL] [Abstract][Full Text] [Related]
14. Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain.
Ross JP; Lockett LJ; Tabor B; Saunders IW; Young GP; Macrae F; Blanco I; Capella G; Brown GS; Lockett TJ; Hannan GN
BMC Cancer; 2014 Jul; 14():475. PubMed ID: 24981199
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.
Dutt SS; Chen N; Darbary HK; Swede H; Petrelli NJ; Stoler DL; Anderson GR
Mutat Res; 2008 Oct; 645(1-2):27-32. PubMed ID: 18778720
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
17. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
Colleran G; McInerney N; Rowan A; Barclay E; Jones AM; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
Breast Cancer Res Treat; 2010 Jan; 119(2):437-42. PubMed ID: 19390964
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of transforming growth factor β receptor I 6A/9A gene polymorphism and breast cancer risk: the picture remains murky.
Ou C; Li H; Liu JH; Drummen GP; Zhu B; Huang LS; Huang Y; Li LQ
Biomarkers; 2015; 20(6-7):487-94. PubMed ID: 26616150
[TBL] [Abstract][Full Text] [Related]
19. Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population.
Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
Med Oncol; 2011 Jun; 28(2):622-5. PubMed ID: 20354825
[TBL] [Abstract][Full Text] [Related]
20. Somatic acquisition and signaling of TGFBR1*6A in cancer.
Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
